Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Rapport Therapeutics, Inc. (RAPP)  
$28.65 1.51 (5.01%) as of 4:30 Tue 12/9


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,660,000
Market Cap: 1.48(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.15 - $31.47
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 13.7
Insider 6 Months    : 13.7
Insider 3/6 Months : 27.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 65,566 65,566 81,566 684,422
Total Buy Value $1,605,585 $1,605,585 $1,767,823 $12,347,406
Total People Bought 3 3 4 5
Total Buy Transactions 3 3 6 8
Total Shares Sold 128,752 159,252 184,752 184,752
Total Sell Value $3,357,397 $3,888,997 $4,143,774 $4,143,774
Total People Sold 3 3 3 3
Total Sell Transactions 10 14 17 17
End Date 2025-09-11 2025-06-10 2024-12-10 2023-12-11

   
Records found: 39
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Gault Cheryl Chief Operating Officer   •       –      –    2025-11-26 4 AS $30.10 $150,487 D/D (5,000) 171,928 0%     
   Gault Cheryl Chief Operating Officer   •       –      –    2025-11-26 4 OE $1.80 $9,000 D/D 5,000 176,928     -
   Bredt David Chief Scientific Officer   •       –      –    2025-11-17 4 AS $24.84 $214,091 D/D (8,500) 401,142 17%     
   Ceesay Abraham Chief Executive Officer   •       •      –    2025-11-17 4 AS $24.91 $128,116 I/I (5,083) 35,978 17%     
   Ceesay Abraham Chief Executive Officer   •       •      –    2025-11-17 4 AS $24.92 $146,931 D/D (5,833) 573,746 17%     
   Bredt David Chief Scientific Officer   •       –      –    2025-10-15 4 AS $25.73 $219,196 D/D (8,500) 409,642 14%     
   Ceesay Abraham Chief Executive Officer   •       •      –    2025-10-15 4 AS $25.75 $131,189 I/I (5,083) 41,061 14%     
   Ceesay Abraham Chief Executive Officer   •       •      –    2025-10-15 4 AS $25.72 $150,541 D/D (5,833) 579,579 14%     
   Ceesay Abraham Chief Executive Officer   •       •      –    2025-09-17 4 AS $26.30 $936,472 I/I (35,585) 46,144 12%     
   Ceesay Abraham Chief Executive Officer   •       •      –    2025-09-17 4 AS $26.30 $1,074,725 D/D (40,835) 585,412 12%     
   Bredt David Chief Scientific Officer   •       –      –    2025-09-15 4 AS $23.88 $205,649 D/D (8,500) 418,142 19%     
   Paul Steven M   –       •      –    2025-09-12 4 B $24.50 $1,027,111 I/I 41,666 41,666 0.01 24%     
   Huber Reid M   –       •      –    2025-09-12 4 B $24.48 $499,374 D/D 20,400 20,400 0.01 24%     
   Young Wendy B.   –       •      –    2025-09-11 4 B $22.60 $79,100 D/D 3,500 9,500 0.01 27%     
   Gault Cheryl Chief Operating Officer   •       –      –    2025-09-08 4 AS $38.33 $191,650 D/D (5,000) 171,928 -6%     
   Gault Cheryl Chief Operating Officer   •       –      –    2025-09-08 4 OE $1.80 $9,000 D/D 5,000 176,928     -
   Bredt David Chief Scientific Officer   •       –      –    2025-08-15 4 AS $14.98 $127,466 D/D (8,500) 426,642 101%     
   Bredt David Chief Scientific Officer   •       –      –    2025-07-15 4 AS $14.00 $118,962 D/D (8,500) 435,142 87%     
   Bredt David Chief Scientific Officer   •       –      –    2025-06-16 4 AS $11.00 $93,522 D/D (8,500) 443,642 134%     
   Bredt David Chief Scientific Officer   •       –      –    2025-05-15 4 AS $9.56 $81,262 D/D (8,500) 452,142 176%     
   Bredt David Chief Scientific Officer   •       –      –    2025-04-15 4 AS $9.57 $81,310 D/D (8,500) 460,642 52%     
   Bredt David Chief Scientific Officer   •       –      –    2025-03-14 4 AS $10.85 $92,205 D/D (8,500) 469,142 58%     
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2025-03-13 4 B $9.98 $998 D/D 100 10,000 0.01 55%     
   Young Wendy B.   –       •      –    2025-03-12 4 B $10.21 $61,250 D/D 6,000 6,000 0.01 52%     
   Ignelzi Troy A. Chief Financial Officer   •       –      –    2025-03-12 4 B $10.10 $99,990 D/D 9,900 9,900 0.01 52%     

  39 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed